
Revolutionizing Therapies for Neurological Diseases
Healthy Aging and Growing-up Healthy
Our mission is to develop innovative, disease-modifying, and life-saving therapies for some of the most debilitating diseases facing society today. We utilize our proprietary, ground-breaking and innovative platforms for development precision and First-in-class therapies and genetic medicines.















Inspired by Nature
Engineered to Heal
We are Developing
Tomorrow's Medicines
Engineering Precision Targeting and Receptor Mediated
We were inspired by nature to engineer and develop potential therapies for most debilitating diseases with no known or limited therapies.
We are a team of internationally renowned scientists who have been recognized globally for our work in drug delivery and research.
We are innovators and entrepreneurs with extensive experience in studying nature of different diseases and designing innovative therapeutics utilising the latest technologies.
We have embarked on an ambitious path of designing First-in-Class therapies that have the potential to be safe for patients and good for the environment.
News & Events

Pioneering Research
Our chief scientist and inventor of our Peptide Therapeutic Platforms:
Professor Moein Moghimi's laboratory has been at the forefront of pioneering and innovative research in nanomedicine, drug delivery, and biomedical engineering for decades. His team's groundbreaking work has led to the development of advanced nanoscale technologies for targeted drug delivery, immune modulation, and diagnostic applications. By exploring novel approaches to nanocarrier design, biocompatibility, and cellular interactions, Professor Moghimi’s research has significantly influenced the fields of nanopharmacology and precision medicine. His lab's discoveries continue to pave the way for safer and more effective therapeutic strategies, with the potential to ultimately transforming patient care and advancing modern medicine.
SMDG is an award-winning biotechnology company, recognised for its groundbreaking therapeutic platforms. Join us on our mission to transform the lives of patients suffering from neurological diseases and other debilitating diseases. Together, we can make a difference.

Dr Farhangrazi recognised as a 2024 CEO of the year leading a life sciences company by the SME News











